Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority)PARIS, July05, 2024(GLOBE NEWSWIRE) -- Listing market: Euronext GrowthISIN code: FR0010425595 DateTotal number of shares in the capitalTotal number of voting rights 06/30/2024100,093,63588,029,364 For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,[email protected] ...
Comunicato Precedente
Comunicato Successivo
New York,
(informazione.it - comunicati stampa - salute e benessere)
![](https://www.globenewswire.com/newsroom/ti?nf=OTE3MzgzMyM2MzU1MjI5IzIwNDk4Nzc=)
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, July 05, 2024 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
Date | Total number of shares in the capital | Total number of voting rights |
06/30/2024 | 100,093,635 | 88,029,364 |
For further information on Cellectis, please contact:
Media contact:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, [email protected]
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contacts:
Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, [email protected]
Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577
Attachment
![](https://ml.globenewswire.com/media/YTgyMTZjNjUtNzcyYy00NDhjLWE0Y2EtMGM2Yzk2YjU3ZTVkLTEwNjE0NDg=/tiny/Cellectis-Inc-.png)
Per maggiori informazioni
Sito Web
cellectis.com
Ufficio Stampa
Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti